Funding · Company

Autobahn Therapeutics, Inc.

San Diego, CABiotech & Pharma

Autobahn Therapeutics, Inc. of San Diego, CA has disclosed $101M across 1 Form D offering filed with the SEC on Aug 1, 2024.

$101M

Total disclosed

Form D offering

Offerings on file

Each amount is as reported on that filing, cumulative across its own amendments. Newest first.

$101M

Form D · Aug 1, 2024 ↗

Q3 2024 · target $120M

Filing details

HeadquartersSan Diego, CAIndustryBiotech & Pharma (Biotechnology)SEC CIK0001815098Offerings on file1

Links

All SEC filings for this company ↗ autobahntherapeutics.com ↗ More biotech & pharma raises →

Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →